Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Short-term Investments (2019 - 2024)

Historic Short-term Investments for KalVista Pharmaceuticals (KALV) over the last 5 years, with Q4 2024 value amounting to $86.0 million.

  • KalVista Pharmaceuticals' Short-term Investments changed N/A to $86.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $86.0 million, marking a year-over-year change of. This contributed to the annual value of $178.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Short-term Investments is $86.0 million.
  • In the past 5 years, KalVista Pharmaceuticals' Short-term Investments ranged from a high of $178.6 million in Q2 2024 and a low of $32.6 million during Q1 2021
  • Moreover, its 4-year median value for Short-term Investments was $57.2 million (2020), whereas its average is $75.5 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 4740.7% in 2021, then soared by 10699.47% in 2024.
  • KalVista Pharmaceuticals' Short-term Investments (Quarter) stood at $39.7 million in 2020, then dropped by 17.92% to $32.6 million in 2021, then soared by 39.66% to $45.5 million in 2023, then surged by 89.03% to $86.0 million in 2024.
  • Its last three reported values are $86.0 million in Q4 2024, $94.2 million for Q4 2024, and $142.4 million during Q3 2024.